Zvi Bentwich
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zvi Bentwich has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Alexander Kalinkovich
R. Ben-Ari Institute of Clinical Immunology and AIDS Center, Hebrew University Hadassah Medical School, Rehovot, Israel
4 shared publicationsGadi Borkow
R. Ben-Ari Institute of Clinical Immunology and AIDS Center, Kaplan Medical Center, Hebrew University Hadassah Medical School, Rehovot, Israel
4 shared publicationsZiva Weisman
4 shared publicationsMiguel Stein
2 shared publicationsAlbert D. Beyers
1 shared publicationAlexander Tsimanis
1 shared publication
Latest Publications
- Open Access
- 1 May 2002
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 9 (3) , 505-507
Host Background Immunity and Human Immunodeficiency Virus Protective Vaccines, a Major Consideration for Vaccine Efficacy in Africa and in Developing Countries
- 1 May 2002
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 9 (3) , 505-507
Open AccessHost Background Immunity and Human Immunodeficiency Virus Protective Vaccines, a Major Consideration for Vaccine Efficacy in Africa and in Developing Countries
- 1 July 2001
- Published by Elsevier in Clinical Immunology
- Vol. 100 (1) , 107-117
Increased CCR5 and CXCR4 Expression in Ethiopians Living in Israel: Environmental and Constitutive Factors
- 1 July 2001
- Published by Elsevier in Clinical Immunology
- Vol. 100 (1) , 107-117
Increased CCR5 and CXCR4 Expression in Ethiopians Living in Israel: Environmental and Constitutive Factors
- Open Access
- 15 October 2000
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 106 (8) , 1053-1060
Chronic immune activation associated with intestinal helminth infections results in impaired signal transduction and anergy
Helminthic parasites cause widespread, persistent infections in humans. The immigration of Ethiopians to Israel (a group denoted here by “Eth.”), many of them infested with helminths and in a chronic immune-activation state, enabled us to investigate the effects of such immune activation on immune responses. We studied the immune profile and immune functions of 190 Eth. and Israeli non-Eth. (Isr.) highly, partially, or non–immune-activated individuals. Immune cells from highly immune-activated individuals were defective in several signaling responses, all of which were restored gradually following anti-helminthic treatment. These cells showed poor transmembrane signaling, as seen by the phosphorylation of various tyrosine kinases and of the MAPK kinases, ERK1/2 and p38; deficient degradation of phosphorylated IκBα; increased expression of cytotoxic T lymphocyte–associated antigen 4 (CTLA-4), which appears to block proliferative responses in these cells; decreased β-chemokine secretion by CD8+ cells after stimulation; and reduced proliferation to recall antigen stimulation. Highly immune-activated individuals also showed decreased delayed-type skin hypersensitivity responses to recall antigen before deworming. These findings support the notion that chronic helminthic infections cause persistent immune activation that results in hyporesponsiveness and anergy. Such impaired immune functions may diminish the capacity of these individuals to cope with infections and to generate cellular protective immunity after vaccination.
- 15 October 2000
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 106 (8) , 1053-1060
Open AccessChronic immune activation associated with intestinal helminth infections results in impaired signal transduction and anergy
Helminthic parasites cause widespread, persistent infections in humans. The immigration of Ethiopians to Israel (a group denoted here by “Eth.”), many of them infested with helminths and in a chronic immune-activation state, enabled us to investigate the effects of such immune activation on immune responses. We studied the immune profile and immune functions of 190 Eth. and Israeli non-Eth. (Isr.) highly, partially, or non–immune-activated individuals. Immune cells from highly immune-activated individuals were defective in several signaling responses, all of which were restored gradually following anti-helminthic treatment. These cells showed poor transmembrane signaling, as seen by the phosphorylation of various tyrosine kinases and of the MAPK kinases, ERK1/2 and p38; deficient degradation of phosphorylated IκBα; increased expression of cytotoxic T lymphocyte–associated antigen 4 (CTLA-4), which appears to block proliferative responses in these cells; decreased β-chemokine secretion by CD8+ cells after stimulation; and reduced proliferation to recall antigen stimulation. Highly immune-activated individuals also showed decreased delayed-type skin hypersensitivity responses to recall antigen before deworming. These findings support the notion that chronic helminthic infections cause persistent immune activation that results in hyporesponsiveness and anergy. Such impaired immune functions may diminish the capacity of these individuals to cope with infections and to generate cellular protective immunity after vaccination.
- 1 November 1999
- Published by Elsevier in Immunology Today
- Vol. 20 (11) , 485-487
Can eradication of helminthic infections change the face of AIDS and tuberculosis?
- 1 November 1999
- Published by Elsevier in Immunology Today
- Vol. 20 (11) , 485-487
Can eradication of helminthic infections change the face of AIDS and tuberculosis?
- 17 June 1999
- Published by Elsevier in Immunology Letters
- Vol. 68 (2-3) , 281-287
Chemokines and chemokine receptors: role in HIV infection
- 17 June 1999
- Published by Elsevier in Immunology Letters
- Vol. 68 (2-3) , 281-287
Chemokines and chemokine receptors: role in HIV infection